--- name: VitroGenLabs Hungary Kft. slug: vitrogenlabs-hungary-llc site: cro website_domain: vitrogenlabs.com summary: GLP-accredited in vitro CRO specializing in OECD-validated skin corrosion, skin irritation, and ocular irritation testing using reconstructed human tissue models. Serves pharmaceutical, cosmetic, chemical, and medical device companies with non-animal alternatives for REACH, CLP, cosmetics, and FDA submissions. Headquartered in Budapest, Hungary. tagline: Non-animal in vitro toxicology for regulatory compliance across REACH, cosmetics, and FDA submissions. founded_year: 2024 employee_count_band: employee_count_label: parent_name: parent_slug: hq_country: HU tier2_domain_verified: false updated_at: 2026-08-15T07:01:11.966Z services_count: 3 modalities_count: 0 indications_count: 0 locations_count: 1 review_signal_gate: closed generated_by: BioBM Editorial AI --- # VitroGenLabs Hungary Kft. Non-animal in vitro toxicology for regulatory compliance across REACH, cosmetics, and FDA submissions. Listed on cro.directory. ## Summary GLP-accredited in vitro CRO specializing in OECD-validated skin corrosion, skin irritation, and ocular irritation testing using reconstructed human tissue models. Serves pharmaceutical, cosmetic, chemical, and medical device companies with non-animal alternatives for REACH, CLP, cosmetics, and FDA submissions. Headquartered in Budapest, Hungary. ## At a glance - Founded: 2024 - HQ country: HU ## Services - In Vitro ADME / DMPK - Preclinical In Vitro Studies - Safety Pharmacology ## Locations - Headquarters, Budapest, Budapest, Hungary ## Certifications - Hungarian GLP Monitoring Authority (NNGYK); Identifier: GLP-accredited; Source: https://vitrogenlabs.com/ - ISO; Identifier: ISO 9001:2015; Source: https://vitrogenlabs.com/ ## Long description ## Overview VitroGenLabs Hungary Kft. is a contract research organization founded in 2024, dedicated to advancing regulatory science through validated in vitro toxicology methods. The organization specializes in non-animal testing alternatives (new approach methodologies, or NAMs) for safety assessment across pharmaceutical, cosmetic, chemical, and medical device sectors. ## Core Services **Validated In Vitro Assays:** - **OECD TG 431** (In Vitro Skin Corrosion using EpiDerm™ reconstructed human epidermis with MTT viability assay) — discriminates corrosive vs. non-corrosive substances and supports UN GHS sub-categorization (Category 1A and 1B/1C) - **OECD TG 439** (In Vitro Skin Irritation using EpiDerm™ RhE model) — distinguishes UN GHS Category 2 irritants from non-irritants - **OECD TG 435** (In Vitro Membrane Barrier Test using CORROSITEX® assay) — bioengineered membrane system suited for organic acids, bases, and surfactants; results within 24 hours - **OECD TG 492B** (Reconstructed Human Corneal Epithelium using SkinEthic™ HCE model) — assesses corneal epithelial cytotoxicity and discriminates UN GHS categories (No Category, Category 2, Category 1) **Emerging Assays in Active Deployment:** - Endocrine disruption screening (ER-CALUX®, VM7Luc4E2 cell lines for estrogen receptor agonism/antagonism; AR-EcoScreen™ for androgen receptor assays; competitive binding assay with full-length recombinant hERα) - Haemocompatibility testing (platelet and leukocyte quantification, thrombosis assessment via TEG, coagulation PT/aPTT, complement activation C3a/SC5b-9, platelet activation) - Medical device biocompatibility (MTT, neutral red uptake, colony formation assays; RHE and RCE irritation models for device extracts and materials per ISO 10993-23) ## Regulatory Compliance & Quality - **GLP Accreditation:** Issued by the Hungarian GLP Monitoring Authority (NNGYK); all studies conducted under OECD Principles of Good Laboratory Practice - **Quality Management:** ISO 9001:2015 certified - **Regulatory Acceptance:** Methods validated by EURL ECVAM and recommended by ICCVAM; study reports formatted for ECHA, EMA, FDA, and EFSA submissions - **Regulatory Frameworks:** Compliant with EU REACH, CLP, EU Cosmetics Regulation 1223/2009, and FDA IND-enabling requirements ## Differentiation VitroGenLabs emphasizes the 3Rs principles (Replace, Reduce, Refine) and positions non-animal toxicology as the future of regulatory science rather than a compromise. The organization offers faster turnaround and reduced costs compared to traditional in vivo testing, aligned with regulatory shifts including upcoming REACH revisions and the FDA Modernization Act 2.0. ## Team Expertise The organization is led by experienced toxicologists with 30+ years of combined expertise: - **In Vitro Study Director:** 13+ years in in vitro toxicology; managed ~1,000 GLP and non-GLP studies; expertise in EpiSkin, EpiDerm, EpiOcular, SkinEthic TTT, EpiOral, EpiGingival, and AMES mutagenicity testing - **Study Director / Clinical Pathology Scientist:** 10+ years in preclinical safety assessment and clinical pathology; GLP-compliant study expertise in hematology, clinical chemistry, coagulation, and hormone analysis (T3, T4, TSH); method development and validation experience ## Related companies - [Nucro-Technics](/companies/nucro-technics) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/nucro-technics/vitrogenlabs-hungary-llc) - [ITR Laboratories](/companies/itrlab) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/itrlab/vitrogenlabs-hungary-llc) - [Axxam](/companies/axxam) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/axxam/vitrogenlabs-hungary-llc) - [JangoCell](/companies/jangocell) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/jangocell/vitrogenlabs-hungary-llc) - [NEPHRIX Biosolutions](/companies/nephrix-biosolutions) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/nephrix-biosolutions/vitrogenlabs-hungary-llc) - [BioLegacy Research](/companies/biolegacy) (Preclinical In Vitro Studies, Safety Pharmacology) — [Compare](/compare/biolegacy/vitrogenlabs-hungary-llc) - [Reaction Biology](/companies/reactionbiology) (In Vitro ADME / DMPK, Preclinical In Vitro Studies) — [Compare](/compare/reactionbiology/vitrogenlabs-hungary-llc) - [AMSbiopharma](/companies/amsbiopharma) (Preclinical In Vitro Studies) — [Compare](/compare/amsbiopharma/vitrogenlabs-hungary-llc) _Profile last updated: 2026-08-15T07:01:11.966Z. Profile facts may include AI-assisted enrichment._ Auto-generated by BioBM Editorial AI for machine-readable profile access.